/Investor DB

Andera Partners — 2023 Investments

10 investments dated 2023 · listed companies and verified rows first · show all

Crescendo Biologicscrescendobiologics.comin𝕏Jul 2023 · $32M✓ verified

Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology.

BiotechHealthtechMedical Devices

Co-investorsQuan CapitalSofinnova PartnersAstellas Venture Management LLCEMBL VenturesFuture Planet CapitalAvlar BioVentures+3 more

Nouscomnouscom.comSeries C · Nov 2023 · $73M✓ verified

Nouscom is a biotech company whose investors page lists its venture capital backers.

BiotechHealthtech

Riccardo Cortese(Co-Founder)Marina Udier(Chief Executive Officer and Board Director)Elisa Scarselli(Chief Scientific Officer and Co-Founder)Alfredo Nicosia(Co-founder)Antonella Folgori(Co-founder)Stefano Colloca(Co-founder)

Co-investors5AM VenturesAngelini VenturesRevelation PartnersXGEN VentureBpifranceEQT Life Sciences+7 more

Amolyt Pharmaamolytpharma.comSeries C · Jan 2023 · $140M

Developing therapeutic peptides targeting rare endocrine diseases (past investment).

Co-investorsATEM Capital FundCTI Life Sciences Fund L.P.EQT Life SciencesKurma PartnersOctalfaSofinnova Partners+3 more

Anetaaneta.companyMay 2023

Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsPebblebedBGVForbionFountain Healthcare PartnersHTGFPMV+2 more

Bioventrixbioventrix.comin𝕏Series A · Apr 2023 · $49M

BioVentrix is a medical device company that develops less invasive therapies to treat heart failure by reconstructing the dilated left ventricle using myocardial micro-anchor implants.

BiotechHealthtechMedical DevicesMansfield, US

DAVID RICHMOND(Executive Officer, Director)inSTEVE CHARTIER(Executive Officer)inJAMES DILLON(Executive Officer, Director)ORI BEN-YEHUDA(Executive Officer)WILLIAM ABBOTT(Executive Officer)inMiller Ken(Executive Officer, Director)

FIRE1fire1foundry.comin𝕏Mar 2023 · $120M

FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.

Digital HealthHardwareMedical DevicesDublin, IE

Co-investorsGimvIreland Strategic Investment FundLightstone VenturesLongitude CapitalNew Enterprise Associates (NEA)Seventure Partners+5 more

mylight150mylight150.cominDec 2023

Mylight150 provides solar panel systems, energy storage solutions, and smart home energy management services for residential customers.

CleantechEnergyIoT

Virgile Suavet(Founder)in

Co-investorsAzora CapitalEiffel Investment GroupElevation Capital

Qualisteoqualisteo.cominSep 2023

Qualisteo provides energy optimization software and smart metering technology for industrial and commercial sites worldwide.

CleantechEnterprise SoftwareSaaS

SoniViesonivie.comSeries C · Jan 2023 · $60M

Co-investorsAccelmed PartnersNovaCapitalSupernova Invest

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ariceum Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.